Literature DB >> 28758095

Clinical presentation and epidemiology of brain tumors firstly diagnosed in adults in the Emergency Department: a 10-year, single center retrospective study.

Ivan Comelli1, Giuseppe Lippi2, Valentina Campana1, Franco Servadei3, Gianfranco Cervellin1.   

Abstract

BACKGROUND: Several patients with new onset brain tumors present to the Emergency Department (ED) complaining for new symptoms. Although information exists on symptom prevalence in the entire population of patients with brain tumors, little is known about the clinical presentation in ED. This retrospective study was planned to investigate clinical presentation and epidemiology of brain tumors firstly diagnosed in a large urban ED throughout a 10-year period.
METHODS: All medical records of patients aged ≥18 years, discharged from our ED with a diagnosis of brain tumor were retrieved from the electronic hospital database during a 10-year period (2006 to 2015). The records were reassessed for selecting only brain tumors firstly diagnosed in the ED. The symptoms at presentation were divided in six categories: (I) headache; (II) seizures; (III) focal signs; (IV) altered mental status; (V) nausea/vomiting/dizziness; (VI) trauma. For all cases, the hospital record was retrieved, to obtain histologic classification of tumors. Patients with inflammatory neoformations were excluded from the study.
RESULTS: Overall, 205 patients with firstly diagnosed brain tumor were identified among 870,135 ED visits (i.e., <1%). Glial tumors were the most frequent (50% of the entire sample). No significant differences were found between mean age of patients in the different histologically based groups (meningiomas 66±14; glioblastomas 65±16 years; metastases 66±13 years; other miscellaneous 66±19 years). Focal signs accounted for more than 50% of all presentation signs/symptoms.
CONCLUSIONS: First presentation of brain tumor in the ED is not a rare occurrence, so that the emergency physicians should be aware of this possibility.

Entities:  

Keywords:  Brain tumor; Emergency Department (ED); astrocytoma; glial tumor; meningioma

Year:  2017        PMID: 28758095      PMCID: PMC5515810          DOI: 10.21037/atm.2017.06.12

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  16 in total

1.  CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Authors:  Quinn T Ostrom; Haley Gittleman; Jordonna Fulop; Max Liu; Rachel Blanda; Courtney Kromer; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-10-27       Impact factor: 12.300

Review 2.  The management of radiation-induced brain injury.

Authors:  Edward G Shaw; Mike E Robbins
Journal:  Cancer Treat Res       Date:  2006

3.  Presenting symptoms of pediatric brain tumors diagnosed in the emergency department.

Authors:  Jackson Lanphear; Syana Sarnaik
Journal:  Pediatr Emerg Care       Date:  2014-02       Impact factor: 1.454

4.  Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.

Authors:  I Baldi; A Gruber; A Alioum; E Berteaud; P Lebailly; A Huchet; T Tourdias; G Kantor; J P Maire; A Vital; H Loiseau
Journal:  Neuro Oncol       Date:  2011-10-06       Impact factor: 12.300

5.  Utilization and cost of health care services associated with primary malignant brain tumors in the United States.

Authors:  Lucie Kutikova; Lee Bowman; Stella Chang; Stacey R Long; Donald E Thornton; William H Crown
Journal:  J Neurooncol       Date:  2006-06-14       Impact factor: 4.130

6.  Brain cancer incidence in the provinces of Zaragoza and Navarre (Spain): effect of age, period and birth cohort.

Authors:  M Ruiz-Tovar; G López-Abente; M Pollán; N Aragonés; E Ardanaz; P Moreo; C Moreno; A Vergara
Journal:  J Neurol Sci       Date:  1999-03-15       Impact factor: 3.181

7.  Effect of disease burden on health-related quality of life in patients with malignant gliomas.

Authors:  D Osoba; M Brada; M D Prados; W K Yung
Journal:  Neuro Oncol       Date:  2000-10       Impact factor: 12.300

8.  Epidemiology of glial and non-glial brain tumours in Europe.

Authors:  Emanuele Crocetti; Annalisa Trama; Charles Stiller; Adele Caldarella; Riccardo Soffietti; Jana Jaal; Damien C Weber; Umberto Ricardi; Jerzy Slowinski; Alba Brandes
Journal:  Eur J Cancer       Date:  2012-01-07       Impact factor: 9.162

Review 9.  Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective.

Authors:  Martin J van den Bent
Journal:  Acta Neuropathol       Date:  2010-07-20       Impact factor: 17.088

10.  Signs and symptoms of patients with brain tumors presenting to the emergency department.

Authors:  H Snyder; K Robinson; D Shah; R Brennan; M Handrigan
Journal:  J Emerg Med       Date:  1993 May-Jun       Impact factor: 1.484

View more
  5 in total

1.  Cancer diagnostics: current concepts and future perspectives.

Authors:  Martina Montagnana; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2017-07

Review 2.  Understanding required to consider AI applications to the field of ophthalmology.

Authors:  Hitoshi Tabuchi
Journal:  Taiwan J Ophthalmol       Date:  2022-04-13

3.  Automated detection of brain metastases on non-enhanced CT using single-shot detectors.

Authors:  Shimpei Kato; Shiori Amemiya; Hidemasa Takao; Hiroshi Yamashita; Naoya Sakamoto; Osamu Abe
Journal:  Neuroradiology       Date:  2021-06-10       Impact factor: 2.804

Review 4.  Reforming support systems of newly diagnosed brain cancer patients: a systematic review.

Authors:  Maria Loizidou; Viktoria Sefcikova; Justyna O Ekert; Matan Bone; George Samandouras
Journal:  J Neurooncol       Date:  2021-11-26       Impact factor: 4.130

5.  Potentially inappropriate brain CT-scan requesting in the emergency department: A retrospective study in patients with neurologic complaints.

Authors:  Hossein Alimohammadi; Shima Zareh Shahamati; Abdolazim Karkhaneh Yousefi; Behnam Safarpour Lima
Journal:  Acta Biomed       Date:  2021-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.